Literature DB >> 8003124

Role of the aldehyde dehydrogenase-1 isozyme in the metabolism of acetaldehyde.

Y Ueshima1, Y Matsuda, M Tsutsumi, A Takada.   

Abstract

At least four types of aldehyde dehydrogenase (ALDH) isozymes exist in human liver: acetaldehyde (Ac-CHO) is metabolized mainly by ALDH2. However, the role of ALDH1 in Ac-CHO metabolism is not well known, because ALDH1 deficiency is rare. In the present study, changes in blood levels of Ac-CHO were analyzed in a person with ALDH1 deficiency who is also heterozygous for the ALDH2 alleles, and subjects with normal ALDH1, in order to clarify the roles of ALDH1 in the metabolism of Ac-CHO. By isoelectric focusing analysis of ALDH in red blood cells (RBC), the ALDH1 band was not detectable in a male subject, indicating ALDH1 deficiency. In this subject, ALDH1 activity was nearly null, but the activities in his wife and two children were normal. Serial changes of blood Ac-CHO levels following a small amount of ethanol were analyzed. The peak levels of Ac-CHO were not different between the subject with ALDH1 deficiency and the person with normal ALDH1. However, the decrease from the peak values of Ac-CHO was clearly slower in the deficient subject than in ALDH1 normal subjects. Changes in Ac-CHO in blood were also analyzed in vitro. Ac-CHO metabolism by RBC from the ALDH1 deficient subjects was clearly slower than in those from controls. These results indicate that ALDH1 plays an important role in the metabolism of Ac-CHO in blood.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8003124     DOI: 10.1093/alcalc/28.supplement_1b.15

Source DB:  PubMed          Journal:  Alcohol Alcohol Suppl        ISSN: 1358-6173


  8 in total

1.  Discovery of a series of aromatic lactones as ALDH1/2-directed inhibitors.

Authors:  Cameron D Buchman; Krishna K Mahalingan; Thomas D Hurley
Journal:  Chem Biol Interact       Date:  2015-01-29       Impact factor: 5.192

2.  Inhibition of the Aldehyde Dehydrogenase 1/2 Family by Psoralen and Coumarin Derivatives.

Authors:  Cameron D Buchman; Thomas D Hurley
Journal:  J Med Chem       Date:  2017-03-06       Impact factor: 7.446

3.  UPLC-MS-based metabolomics reveals metabolic dysregulation in ALDH1A1-overexpressed lung adenocarcinoma cells.

Authors:  Yang Wang; Cong-Hui Wang; Yu-Fei Zhang; Liang Zhu; Hui-Min Lei; Ya-Bin Tang
Journal:  Metabolomics       Date:  2019-03-25       Impact factor: 4.290

4.  Evaluation of aldehyde dehydrogenase 1 promoter polymorphisms identified in human populations.

Authors:  John P Spence; Tiebing Liang; C J Peter Eriksson; Robert E Taylor; Tamara L Wall; Cindy L Ehlers; Lucinda G Carr
Journal:  Alcohol Clin Exp Res       Date:  2003-09       Impact factor: 3.455

Review 5.  Non-P450 aldehyde oxidizing enzymes: the aldehyde dehydrogenase superfamily.

Authors:  Satori A Marchitti; Chad Brocker; Dimitrios Stagos; Vasilis Vasiliou
Journal:  Expert Opin Drug Metab Toxicol       Date:  2008-06       Impact factor: 4.481

6.  A comparison of CRISPR/Cas9 and siRNA-mediated ALDH2 gene silencing in human cell lines.

Authors:  Fei Wang; Tao Guo; Hongmei Jiang; Ruobi Li; Ting Wang; Ni Zeng; Guanghui Dong; Xiaowen Zeng; Daochuan Li; Yongmei Xiao; Qiansheng Hu; Wen Chen; Xiumei Xing; Qing Wang
Journal:  Mol Genet Genomics       Date:  2018-01-30       Impact factor: 3.291

Review 7.  Aldehyde dehydrogenases in cellular responses to oxidative/electrophilic stress.

Authors:  Surendra Singh; Chad Brocker; Vindhya Koppaka; Ying Chen; Brian C Jackson; Akiko Matsumoto; David C Thompson; Vasilis Vasiliou
Journal:  Free Radic Biol Med       Date:  2012-11-27       Impact factor: 7.376

8.  A specific inhibitor of ALDH1A3 regulates retinoic acid biosynthesis in glioma stem cells.

Authors:  Jianfeng Li; Silvia Garavaglia; Zhaofeng Ye; Andrea Moretti; Olga V Belyaeva; Alison Beiser; Md Ibrahim; Anna Wilk; Steve McClellan; Alla V Klyuyeva; Kelli R Goggans; Natalia Y Kedishvili; E Alan Salter; Andrzej Wierzbicki; Marie E Migaud; Steven J Mullett; Nathan A Yates; Carlos J Camacho; Menico Rizzi; Robert W Sobol
Journal:  Commun Biol       Date:  2021-12-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.